Grant opportunity · PAR-25-266
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Who can apply (as listed)
- City or township governments
- Private institutions of higher education
- State governments
- Public and state-controlled institutions of higher education
- Independent school districts
- Public housing authorities / Indian housing authorities
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Special district governments
- Small businesses
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- For-profit organizations (other than small businesses)
- Native American tribal governments (federally recognized)
- Native American tribal organizations (other than federally recognized governments)
- Others (see the opportunity text)
- County governments
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a "high priority" condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment.
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.